NCT05456074View on ClinicalTrials.gov

Integrative Molecular Characterization Of MiT Family Translocation Renal Cell Carcinomas (IMCOR)

Not yet recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

January 25, 2023

Primary Completion Date

January 25, 2026

Study Completion Date

January 25, 2026

Conditions
Renal Carcinoma
Interventions
OTHER

Data collection

Retrospective data collection

Trial Locations (4)

67033

Institut de cancérologie Strasbourg Europe, Strasbourg

Unknown

Réseau Français de Recherche sur le Cancer du Rein (UroCCR), Bordeaux

Réseau SIOP, Hôpital Trousseau, Paris

Réseau CARARE, Rennes

All Listed Sponsors
collaborator

National Cancer Institute, France

OTHER_GOV

collaborator

Ministry of Health, France

OTHER_GOV

lead

Institut de cancérologie Strasbourg Europe

OTHER

NCT05456074 - Integrative Molecular Characterization Of MiT Family Translocation Renal Cell Carcinomas (IMCOR) | Biotech Hunter | Biotech Hunter